# FDA 483 - Xinfa Pharmaceutical Co., Ltd - April 05, 2016

Source: https://www.globalkeysolutions.net/records/483/xinfa-pharmaceutical-co-ltd/a56a553b-1990-4522-9806-04e03135b1fd

> FDA 483 for Xinfa Pharmaceutical Co., Ltd on April 05, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Xinfa Pharmaceutical Co., Ltd
- Inspection Date: 2016-04-05
- Product Type: drugs
- Office Name: Office of Compliance Intervention and Consultation
- Summary: An FDA inspection of Xinfa Pharmaceutical Co., Ltd. in Dongying, China, revealed significant concerns regarding manufacturing practices for dietary supplement ingredients. Observations included product residue on equipment deemed clean and released by Quality Control, as well as insufficient lighting for proper equipment inspection. These findings indicate potential deficiencies in quality control and facility maintenance.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/rachel-a-gomez/fe18202f-6816-4537-916b-943deefafd4a)

Company: https://www.globalkeysolutions.net/companies/xinfa-pharmaceutical-co-ltd/a08976d0-2ca1-45bc-a7e6-49772b0e875d

Office: https://www.globalkeysolutions.net/offices/office-of-compliance-intervention-and-consultation/0b3cfe41-f423-41e0-b1a1-caab23b32d54